Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Effects of VEGF and VEGFR polymorphisms on the outcome of patients with metastatic renal cell carcinoma treated with sunitinib: a systematic review and meta-analysis.

Miao C, Cao J, Wang Y, Liu B, Wang Z.

Oncotarget. 2017 Aug 4;8(40):68854-68862. doi: 10.18632/oncotarget.19924. eCollection 2017 Sep 15.

2.

Lymphangiogenesis guidance by paracrine and pericellular factors.

Vaahtomeri K, Karaman S, Mäkinen T, Alitalo K.

Genes Dev. 2017 Aug 15;31(16):1615-1634. doi: 10.1101/gad.303776.117. Review.

3.

Drug delivery approaches for breast cancer.

Singh SK, Singh S, Lillard JW Jr, Singh R.

Int J Nanomedicine. 2017 Aug 24;12:6205-6218. doi: 10.2147/IJN.S140325. eCollection 2017. Review.

4.

The optimum marker for the detection of lymphatic vessels.

Kong LL, Yang NZ, Shi LH, Zhao GH, Zhou W, Ding Q, Wang MH, Zhang YS.

Mol Clin Oncol. 2017 Oct;7(4):515-520. doi: 10.3892/mco.2017.1356. Epub 2017 Jul 31.

5.

Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation.

Dieterich LC, Ducoli L, Shin JW, Detmar M.

Sci Data. 2017 Aug 29;4:170106. doi: 10.1038/sdata.2017.106.

6.

Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways.

Tan W, Pan M, Liu H, Tian H, Ye Q, Liu H.

Onco Targets Ther. 2017 Jul 13;10:3467-3474. doi: 10.2147/OTT.S139009. eCollection 2017.

7.

CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.

Xiong Y, Huang F, Li X, Chen Z, Feng D, Jiang H, Chen W, Zhang X.

Int J Oncol. 2017 Jul;51(1):75-90. doi: 10.3892/ijo.2017.4003. Epub 2017 May 17.

8.

Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.

Birbrair A, Sattiraju A, Zhu D, Zulato G, Batista I, Nguyen VT, Messi ML, Solingapuram Sai KK, Marini FC, Delbono O, Mintz A.

Stem Cells Transl Med. 2017 Feb;6(2):471-481. doi: 10.5966/sctm.2016-0007. Epub 2016 Sep 14.

9.

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer.

Ribatti D, Nico B, Ruggieri S, Tamma R, Simone G, Mangia A.

Transl Oncol. 2016 Oct;9(5):453-457. doi: 10.1016/j.tranon.2016.07.002. Review.

10.
11.

VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes.

Igarashi Y, Chosa N, Sawada S, Kondo H, Yaegashi T, Ishisaki A.

Int J Mol Med. 2016 Apr;37(4):1005-13. doi: 10.3892/ijmm.2016.2502. Epub 2016 Feb 25.

12.

Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo.

Ma WH, Liu YC, Xue ML, Zheng Z, Ge YL.

Oncol Lett. 2016 Jan;11(1):159-167. Epub 2015 Nov 5.

13.

Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Yang JF, Walia A, Huang YH, Han KY, Rosenblatt MI, Azar DT, Chang JH.

Surv Ophthalmol. 2016 May-Jun;61(3):272-96. doi: 10.1016/j.survophthal.2015.12.004. Epub 2015 Dec 17. Review.

14.
15.

Endothelial Snail Regulates Capillary Branching Morphogenesis via Vascular Endothelial Growth Factor Receptor 3 Expression.

Park JA, Kim DY, Kim YM, Lee IK, Kwon YG.

PLoS Genet. 2015 Jul 6;11(7):e1005324. doi: 10.1371/journal.pgen.1005324. eCollection 2015 Jul.

16.

VEGFR3 does not sustain retinal angiogenesis without VEGFR2.

Zarkada G, Heinolainen K, Makinen T, Kubota Y, Alitalo K.

Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):761-6. doi: 10.1073/pnas.1423278112. Epub 2015 Jan 5.

17.

Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.

Stagg BC, Uehara H, Lambert N, Rai R, Gupta I, Radmall B, Bates T, Ambati BK.

Cancers (Basel). 2014 Nov 26;6(4):2330-42. doi: 10.3390/cancers6042330.

18.
19.

Cancer stem cells and tumor metastasis (Review).

Li S, Li Q.

Int J Oncol. 2014 Jun;44(6):1806-12. doi: 10.3892/ijo.2014.2362. Epub 2014 Apr 2. Review.

20.

VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma.

Du LC, Chen XC, Wang D, Wen YJ, Wang CT, Wang XM, Kan B, Wei YQ, Zhao X.

Reprod Biol Endocrinol. 2014 Feb 6;12:14. doi: 10.1186/1477-7827-12-14.

Supplemental Content

Support Center